The percentage of IFNγ+ cells that expressed CCR6 was significantly enriched within CSF as compared to the peripheral blood, although this enrichment was observed for both MS and OND cohorts (Fig. 1C); these cells represented approximately 50% of the CSF IFNγ-secreting population. The gene discussed is CSF2; the disease is myeloid sarcoma.